The fund infusion through preferential allotment is part of CDR package BS Reporter | Chennai November 26, 2014 Last Updated at 20:30 IST Orchid Healthcare Pvt Ltd, a promoter group firm of Orchid Chemicals and Pharmaceuticals Ltd, would pick up stakes to ... Business Standard, 2 days ago
Promoter group to infuse Rs. 92 crore in Orchid Healthcare; stock 2% up - India Infoline, 1 day ago
1 images for "orchid chemicals and pharmaceuticals"
CHENNAI: In a relief to beleaguered Orchid Chemicals and Pharmaceuticals Ltd, Madras High Court has set aside ING Vysya Bank declaring the pharma major as a willful defaulter and publish photographs of company's CMD K Raghavendra Rao and that of the ...New Indian Express, 1 week ago Orchid Pharma eyes full-capacity utilisation Business Standard India, 1 week ago Orchid Chemicals & Pharmaceuticals reports standalone net profit of Rs 271.94 crore in the September 2014 quarter Business Standard, 2 weeks ago Orchid Chemicals may head above Rs 80: Pritesh Mehta Money Control, 2 weeks ago
Orchid Chemicals and Pharmaceuticals has reported a net profit for the quarter ended September 30 due to extraordinary gain from transfer of the Penicillin and Penem API business. After adjusting for the extraordinary gain of ₹319 crore from ...Hindu Business Line, 2 weeks ago Orchid Chemicals & Pharmaceuticals : Gains from business transfer put Orchid Chem in the black in Q2 4 Traders, 1 week ago
4:35 am Natco Pharma and Orchid Chemicals and Pharmaceuticals have received an adverse observation report, commonly known as Form 483, after inspections conducted in their manufacturing units earlier this year by the US Food and Drug ...BioSpace, 2 months ago Orchid Chemicals & Pharmaceuticals : NATCO, ORCHID GETS A STRONG DOSE OF US FDA MEDICINE 4 Traders, 2 months ago Natco Pharma, Orchid Chemicals get a strong dose of US FDA medicine Financial Express, 2 months ago
The Court says that the decision is taken keeping the larger public interest in mind, as 25 other banks are involved BS Reporter | Chennai November 17, 2014 Last Updated at 20:20 IST The Madras High Court has issued an order in favour of a petition filed by ...Business Standard, 1 week ago
Cyrus Poonawalla, the billionaire horse breeder and chairman of Serum Institute, one of the world's largest vaccine makers, has said he would entertain an offer for his 14.5% stake in Orchid Chemicals at the right price. There's buzz in the market ...Times of India, 1 month ago CYRUS POONAWALLA : Poonawalla awaits right price for stake in Orchid Chemicals 4 Traders, 4 weeks ago
Top News US court not granted Ranbaxy appeal to block ANDA nod Ranbaxy Laboratories Ltd said that the Court has not granted Temporary Restraining Order to block FDA approval for other ANDAs for generic version of Nexium and Valganciclovir.India Infoline, 10 hours ago
Despite reduction in prices of several medicines by NPPA, quality problems with US FDA, competition and slowdown in approvals, 50 top Indian pharmaceutical companies registered satisfactory growth in net sales and earnings before depreciation, ...PharmaBiz, 4 days ago
Plant it bought in Orchid deal cited with Form 483 and observations Share Tools Hospira, already dealing with FDA problems at two plants in India, has bought itself some more issues with the FDA. About three months before Hospira closed on its ...FiercePharmaManufacturing, 2 months ago New FDA concerns arise for Hospira plant in Australia FiercePharmaManufacturing, 1 month ago
Oil and Natural Gas Corp has finalized a price between $10.10 and $11.20 per unit for gas produced from its marginal fields, oil minister Dharmendra Pradhan has said. (BS) Rating agency Moody's has downgraded Indian Overseas Bank's financial ...India Infoline, 1 day ago Top Corporate News of the day-18 November, 2014 India Infoline, 1 week ago
on your WebpageAdd Widget >Get your members hooked!